Menu
Washingtoner
  • Home
  • Financial
  • Construction
  • Home
  • Business
  • Technology
  • Marketing
  • Education
  • Non-profit
Washingtoner

Adare Biome™ Enters North American Distribution Through Stratum Nutrition® for LBiome™ Postbiotic
Washingtoner/10101202

Trending...
  • New Year, New Home: Begin 2026 at Heritage at South Brunswick
  • South Spokane Resident Arrives Home To Find Male Burglarizing Apartment; Resident Assaulted Before Suspect Flees The Area
  • Spokane City Council To Hold Special Legislative Session
26-171491
CARTHAGE, Mo. - Washingtoner -- Stratum Nutrition®, (a business of ESM Technologies), and Adare Biome™, (a division of Adare Pharma Solutions) have entered into a value-added distribution agreement for LBiome™, a unique postbiotic composed of 2 human-origin strains that have been heat-stabilized with its culture medium. LBiome™, also known as Lactobacillus LB, has been used as a digestive health solution for over a century. This alliance adds strategic value for both companies within the dietary supplement marketplace.

Researched in postbiotic form for over 100 years, LBiome™ is the "Pioneer in Postbiotics", with 18 published clinical studies showing digestive health support for both adult and pediatric populations. LBiome™ provides the digestive benefits of a probiotic and the formulation flexibility of a spore, with none of the stability or manufacturing concerns.

Studies have shown that LBiome™ cells adhere to intestinal epithelial cells (the type of cells that line the gut) and strengthen the connections (tight junctions) between these cells. LBiome™ has been shown to rapidly calm lower GI upset as evidenced in the many published clinical studies that have demonstrated the beneficial effects of LBiome™.

More on Washingtoner
  • CCHR White Paper Urges Government Crackdown on Troubled Teen and For-Profit Psychiatric Facilities
  • Still Searching for the Perfect Valentine's Gift? Lick Personal Oils Offers Romantic, Experience-Driven Alternatives to Traditional Presents
  • Boston Industrial Solutions' BPA Certified BX Series Raises the Bar for Pad Printing Inks
  • Tacoma: Community Event Funding Announced for 2026
  • Boston Corporate Coach™ Sets Global Standard for Executive Chauffeur Services Across 680 Cities

"Postbiotics are an emerging category of biotics in the microbiome space, having shown very interesting properties and benefits in which Adare Biome has an expertise as an organization in that area", said Frederic Appert, Vice President & Business Unit Leader at Adare Biome. "We are excited to be partnering with Stratum Nutrition to make our technology available in the US dietary supplement market."

Micah Osborne, President of Stratum Nutrition said, "It is exciting to enter the digestive health category by bringing a unique ingredient for gut health into Stratum's highly selective portfolio. As more customers want alternative delivery options with human-derived strains, we see big opportunities for this health category and look forward to sharing with the industry the efficacy and flexibility of the postbiotic ingredient, LBiome™. It is an honor to partner with Adare, a company with a legacy of developing and manufacturing innovative products of the highest integrity."

For more information about Stratum Nutrition and its branded ingredients, please email info@StratumNutrition.com.

###

About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on Washingtoner
  • UK Financial Ltd Announces CoinMarketCap Supply Verification And Market Positioning Review For Regulated Security Tokens SMPRA And SMCAT
  • Sharpe Automotive Redefines Local Car Care with "Transparency-First" Service Model in Santee
  • South Spokane Resident Arrives Home To Find Male Burglarizing Apartment; Resident Assaulted Before Suspect Flees The Area
  • Spokane City Council Votes on Department of Justice Grant
  • Spokane: Firefighters Contain Fire After Car Crashes Into Home

About Adare Biome
Adare Biome is a division of Adare Pharma Solutions focused on postbiotic production through a proprietary ECHO™ fermentation process.  Adare Biome operates from Houdan, France, a GMP Drug facility for microbial fermentation.  Adare Biome's activity is to develop, produce, and commercialize microbiological products including its pharmaceutical product Lactéol™, and its ingredient for digestive health applications, LBiome™.   Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, development, and manufacturing. To learn more visit www.adarepharmasolutions.com.

Contact
Jacqueline Rizo
***@stratumnutrition.com


Source: Stratum Nutrition

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • CryptaBox Introduces a Hardware Crypto Cold Storage Wallet
  • YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
  • Yesyal Launches Official Website, Unifying Music, Film, and Apparel Under One Independent Brand
  • A Statement from the Tacoma City Council Regarding Community Safety Standards and Law Enforcement
  • High-End Exterior House Painting in Boulder, Colorado
  • Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
  • Spokane: City Closures Planned for MLK Jr. Day
  • Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
  • Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
  • New Year, New Home: Begin 2026 at Heritage at South Brunswick
  • Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
  • Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025
  • Beat the Winter Blues: Paws, Play & Positivity Pop-Up Class Supports Pets and Their People This January
  • CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
  • ASR Media, Social T Marketing & PR Announce Merger
  • $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
  • The 3rd Annual Newark Summit for Real Estate, Economic Development & Placemaking Returns February 9th
  • Ski Safety Awareness Month highlights why seeing clearly and wearing modern protection matters more than ever
  • Vent Pros Expands Operations into Arizona to Meet Growing Demand for Commercial Ventilation and Kitchen Hood Cleaning Services
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane Police Department and SPD Cadets Engage with the Logan Community to Discuss Crime Prevention in the Neighborhood - 153
  • Spokane: Flags to be Lowered for Trooper Killed in Line of Duty
  • City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
  • Tacoma: Homicide Investigation – 3500 block of E Grandview Ave
  • TBM Council Appoints Four Distinguished Leaders to Board of Directors
  • Spokane: City Closures Planned for the Holidays
  • Tacoma: Update in SR-509 Fatal Collision Investigation: Vehicle of Interest Impounded
  • City of Tacoma Launches Pilot Program to Fast-Track ‘Missing Middle’ Housing
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence

Similar on Washingtoner

  • CCHR White Paper Urges Government Crackdown on Troubled Teen and For-Profit Psychiatric Facilities
  • Still Searching for the Perfect Valentine's Gift? Lick Personal Oils Offers Romantic, Experience-Driven Alternatives to Traditional Presents
  • Automation, innovation in healthcare processes featured at international conference in Atlanta
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • Beat the Winter Blues: Paws, Play & Positivity Pop-Up Class Supports Pets and Their People This January
  • CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
  • Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
  • New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
  • Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
  • The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute